Propanc Biopharma, Inc. (PPCB)

Profile

Full Name

Propanc Biopharma, Inc.

Ticker

NASDAQ: PPCB

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Australia

IPO

November 12, 2012

Indexes

Not included

Website

https://www.propanc.com

Employees

1

Key Details

Price

$3.02(-3.21%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$0.02(+98.89% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $3.02
    PPCB price is $3.02

    30-Day Relative Volume

    0.05
    PPCB 30-day relative volume is 0.05

    Price Performance

    Price Today change

    -3.21%
    PPCB price is down -3.21% today

    Price YTD change

    +754900%
    PPCB price is up +754900% since January 1st

    Price 1-year change

    +377400%
    PPCB price is up +377400% year-on-year

    Price 3-year change

    -16.11%
    PPCB price is down -16.11% over the past 3 years

    Price Range

    Price All-time high

    $250.00B
    PPCB price is currently -100.00% below its historical high of $250.00 billion

    Price 3-year low

    $0.00
    PPCB price is currently >+9900.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $35.07M
    PPCB market capitalization is $35.07 million

    Market cap 3-year change

    +100%
    PPCB market capitalization is up +100% over the past 3 years

    Market cap All-time high

    $127.73M
    PPCB market capitalization is currently -72.55% below its historical high of $127.73 million

    Market cap sector rank

    28.36%
    PPCB market capitalization is higher than 28.36% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +124758.06%
    PPCB shares outstanding is up +124758.06% year-on-year

    Shares Outstanding 3-Year Change

    +100%
    PPCB shares outstanding is up +100% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    -8355.23
    PPCB beta is -8355.23

    200-day SMA

    $4.25
    PPCB price is currently -28.87% below its 200-day simple moving average

    50-day SMA

    $5.42
    PPCB price is currently -44.23% below its 50-day simple moving average

    RSI

    43.35
    PPCB 14-day relative strength index is 43.35

    Volume

    0.05
    PPCB 30-day relative volume is 0.05

    ATR

    $1.94
    PPCB average true range is $1.94

    10-day Historical Volatility

    715.28%
    PPCB 10-day historical volatility is 715.28%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    PPCB annual revenue is $0.00

    Revenue Analysts estimate

    -
    PPCB annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    PPCB annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.67%
    PPCB annual revenue is higher than 28.67% of companies in Healthcare sector

    EPS

    EPS

    -$0.02
    PPCB annual earnings per share is -$0.02

    EPS Analysts estimate

    -
    PPCB annual earnings per share consensus analysts' forecast is unknown

    EPS 1-year change

    +98.89%
    PPCB annual earnings per share is up +98.89% year-on-year

    EPS Sector rank

    74.75%
    PPCB annual earnings per share is higher than 74.75% of companies in Healthcare sector

    Profit

    Gross profit

    -$21.70K
    PPCB annual gross profit is -$21.70 thousand

    Gross margin

    -
    PPCB annual gross profit margin value is unknown

    Operating profit

    -$1.54M
    PPCB annual operating income is -$1.54 million

    Operating margin

    -
    PPCB annual operating profit margin value is unknown

    Net income

    -$1.82M
    PPCB annual net profit is -$1.82 million

    Net margin

    -
    PPCB annual net profit margin value is unknown

    Expenses

    Total expenses

    $1.82M
    PPCB annual total expenses is $1.82 million

    Operating expenses

    $1.51M
    PPCB annual total operating expenses is $1.51 million

    Cost of goods sold

    $21.70K
    PPCB annual cost of goods sold is $21.70 thousand

    Selling, general & administrative expenses

    $1.25M
    PPCB annual SGA is $1.25 million

    Depreciation and amortization

    $21.70K
    PPCB annual depreciation & amortization is $21.70 thousand

    Interest expense

    $0.00
    PPCB annual interest expense is $0.00

    Income tax

    -$129.10K
    PPCB annual income tax is -$129.10 thousand

    EBIT & EBITDA

    EBIT

    -$1.54M
    PPCB annual earnings before interest & taxes is -$1.54 million

    EBITDA

    -$1.51M
    PPCB annual EBITDA is -$1.51 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $72.40K
    PPCB annual total assets is $72.40 thousand

    Non current assets

    $47.00K
    PPCB annual long term assets is $47.00 thousand

    Current assets

    $25.40K
    PPCB annual total current assets is $25.40 thousand

    Cash and cash equivalents

    $21.10K
    PPCB annual cash & cash equivalents is $21.10 thousand

    Accounts receivable

    -
    PPCB annual accounts receivable value is unknown

    Inventory

    $0.00
    PPCB annual inventory is $0.00

    Liabilities

    Total liabilities

    $3.85M
    PPCB annual total liabilities is $3.85 million

    Long term liabilities

    $58.60K
    PPCB annual total long term liabilities is $58.60 thousand

    Current liabilities

    $3.79M
    PPCB annual total current liabilities is $3.79 million

    Accounts payable

    $1.21M
    PPCB annual accounts payable is $1.21 million

    Debt

    Total debt

    $948.30K
    PPCB annual total debt is $948.30 thousand

    Total debt 1-year change

    +97.56%
    PPCB annual total debt is up +97.56% year-on-year

    Long term debt

    $58.60K
    PPCB annual long term debt is $58.60 thousand

    Short term debt

    $889.60K
    PPCB annual short term debt is $889.60 thousand

    Equity & Capital

    Shareholders equity

    -$3.78M
    PPCB annual stockholders equity is -$3.78 million

    Book value

    -$100.00
    PPCB annual book value is -$100.00

    Retained earnings

    -$66.70M
    PPCB annual retained earnings is -$66.70 million

    Working capital

    -$3.77M
    PPCB annual working capital is -$3.77 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$935.10K
    PPCB annual cash flow from operations is -$935.10 thousand

    Cash from operations 1-year change

    +15.4%
    PPCB annual cash flow from operations is up +15.4% year-on-year

    Cash from investing

    $0.00
    PPCB annual cash flow from investing activities is $0.00

    Cash from investing 1-year change

    0%
    PPCB annual cash flow from investing activities has remained unchanged year-on-year

    Cash from financing

    $941.90K
    PPCB annual cash flow from financing activities is $941.90 thousand

    Cash from financing 1-year change

    -15.43%
    PPCB annual cash flow from financing activities is down -15.43% year-on-year

    CAPEX

    CAPEX

    $0.00
    PPCB annual capital expenditures is $0.00

    CAPEX 1-year change

    0%
    PPCB annual capital expenditures has remained unchanged year-on-year

    Free Cash Flow

    Free cash flow

    -$935.10K
    PPCB annual free cash flow is -$935.10 thousand

    Free cash flow 1-year change

    +15.4%
    PPCB annual free cash flow is up +15.4% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    PPCB annual gross profit margin value is unknown

    Operating margin

    -
    PPCB annual operating profit margin value is unknown

    Net margin

    -
    PPCB annual net profit margin value is unknown

    ROA & ROE

    ROA

    -2743.78%
    PPCB annual return on assets is -2743.78%

    ROE

    48.17%
    PPCB annual return on equity is 48.17%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    PPCB price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    PPCB price to earnings ratio is unknown

    PB Ratio

    PB ratio

    1.94
    PPCB price to book ratio is 1.94

    PB ratio Sector rank

    53.2%
    PPCB price to book ratio is higher than 53.2% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    PPCB price to sales ratio value is unknown

    PS ratio Sector rank

    -
    PPCB price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $36.26M
    PPCB enterprise value is $36.26 million

    Enterprise value Sector rank

    35.86%
    PPCB enterprise value is higher than 35.86% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.67
    PPCB EV/EBITDA is -0.67

    EV/EBITDA Sector rank

    51.46%
    PPCB EV/EBITDA is higher than 51.46% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.01
    PPCB annual current ratio is 0.01

    Quick ratio

    0.01
    PPCB annual quick ratio is 0.01

    Leverage

    Debt to equity

    -0.25
    PPCB annual debt to equity ratio is -0.25

    Interest coverage ratio

    -
    PPCB annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    PPCB piotroski f-score value is unknown

    Altman Z-Score

    -1416.74
    PPCB altman z-score is -1416.74

    Analyst ratings

    Recent major analysts updates

    No data about analysts updates

    Institutional Ownership

    Screeners with PPCB included

    Growing Shares Outstanding
    Stocks below SMA 200
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Best performing stocks last 12 months
    Biotech Companies
    Best performing stocks YTD
    Ex Dividend dates calendar
    • What is the ticker symbol for Propanc Biopharma, Inc.?
    • Does Propanc Biopharma, Inc. pay dividends?
    • What sector is Propanc Biopharma, Inc. in?
    • What industry is Propanc Biopharma, Inc. in?
    • What country is Propanc Biopharma, Inc. based in?
    • When did Propanc Biopharma, Inc. go public?
    • Is Propanc Biopharma, Inc. in the S&P 500?
    • Is Propanc Biopharma, Inc. in the NASDAQ 100?
    • Is Propanc Biopharma, Inc. in the Dow Jones?
    • When does Propanc Biopharma, Inc. report earnings?

    What is the ticker symbol for Propanc Biopharma, Inc.?

    The ticker symbol for Propanc Biopharma, Inc. is NASDAQ:PPCB

    Does Propanc Biopharma, Inc. pay dividends?

    No, Propanc Biopharma, Inc. does not pay dividends

    What sector is Propanc Biopharma, Inc. in?

    Propanc Biopharma, Inc. is in the Healthcare sector

    What industry is Propanc Biopharma, Inc. in?

    Propanc Biopharma, Inc. is in the Biotechnology industry

    What country is Propanc Biopharma, Inc. based in?

    Propanc Biopharma, Inc. is headquartered in Australia

    When did Propanc Biopharma, Inc. go public?

    Propanc Biopharma, Inc.'s initial public offering (IPO) was on November 12, 2012

    Is Propanc Biopharma, Inc. in the S&P 500?

    No, Propanc Biopharma, Inc. is not included in the S&P 500 index

    Is Propanc Biopharma, Inc. in the NASDAQ 100?

    No, Propanc Biopharma, Inc. is not included in the NASDAQ 100 index

    Is Propanc Biopharma, Inc. in the Dow Jones?

    No, Propanc Biopharma, Inc. is not included in the Dow Jones index

    When does Propanc Biopharma, Inc. report earnings?

    The date for Propanc Biopharma, Inc.'s next earnings report has not been announced yet
    On this page